Integrated biologics and vaccine development

BE BioSol provides aseptic cartridge-filling services for biologics and complex injectable products intended for use in reusable pens, autoinjectors and other patient-friendly delivery systems. Our integrated teams support programs from formulation and process development through technology transfer, valid...

BE BioSol provides integrated process-development support for biologics, vaccines and recombinant proteins. Our capabilities include cell-line and clone selection, media and feed optimization, fermentation and cell-culture process development, and scale-up. Downstream services include harvest clarification...

BE BioSol provides flexible sterile-manufacturing solutions that support injectable products from early clinical development through launch and sustained commercial supply. Our capabilities span liquid and lyophilized vials, prefilled syringes and cartridges, enabling clients to select the presentation and...

BE BioSol provides flexible clinical-supply manufacturing for biologics, vaccines and sterile injectable products, supporting programs from early-phase development through pivotal clinical studies. Our teams work closely with clients to establish practical, phase-appropriate manufacturing strategies that b...

BE BioSol supports the efficient transfer of established commercial products into our manufacturing facilities while protecting product quality, regulatory compliance and continuity of supply. Our cross-functional teams develop structured transfer plans based on a detailed assessment of the existing proces...

BE BioSol provides formulation and drug-product development services designed to improve product stability, manufacturability and delivery. Capabilities include buffer and excipient screening, pH and concentration optimization, stability and stress studies, container-closure compatibility, and lyophilizati...

BE BioSol provides an integrated pathway that supports biologics, vaccines and sterile injectable products from early development through clinical manufacturing and dependable commercial supply. By bringing scientific, technical, regulatory and manufacturing expertise together within one organization, we h...

BE BioSol provides integrated formulation, lyophilization-cycle development and aseptic vial-filling services for biologics, vaccines and complex injectable products requiring enhanced stability or extended shelf life. Our teams support programs from early development and clinical manufacturing through pro...

BE BioSol is expanding its mammalian drug-substance manufacturing capabilities with four 5,000 L single-use bioreactor trains, providing up to 20,000 L of total production capacity. The flexible, modular design will support efficient product changeover, parallel manufacturing campaigns and scalable product...

BE BioSol offers scalable microbial-fermentation capabilities ranging from 50 L to 4,000 L, supporting the development and manufacture of vaccines, recombinant proteins and other microbial-derived biological products. This flexible capacity enables clients to select the appropriate scale for process develo...

BE BioSol provides aseptic prefilled-syringe filling for biologics, vaccines and complex injectable products, supporting clinical and commercial programs. Our integrated services include formulation and drug-product development, process optimization, technology transfer, sterile filtration, aseptic filling...

BE BioSol provides integrated process characterization, scale-up and technology-transfer support designed to move biologics, vaccines and sterile injectable products efficiently from development into clinical and commercial manufacturing. Our cross-functional teams work with clients to build a clear unders...